Agios

This is a preliminary report on Agios’s security posture. If you want in-depth, always up-to-date reports on Agios and millions of other companies, consider booking a demo with us. UpGuard is the new standard in third-party risk management and attack surface management. Our security ratings engine monitors billions of data points each day.

UpGuard Security Rating

${grade.letter}
${cstarScore}
/ 950
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Agios has good security practices.

Company info

Agios
Company
Agios
Employees
Location
CEO
David Schenkein
Last updated
Last updated
Industries
Last updated today

Security report for Agios

Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Agios Data Breaches and Security News

Relevant news, breaches and security articles relating to Agios.
No recent security news.

More security reports

Compare Agios's security performance with other companies.

Sign up to our newsletter

Get curated cybersecurity news and updates in your inbox every week.
Abstract shapeAbstract shape
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
Website Security scan resultsWebsite Security scan ratingAbstract shape

Book a free demo

Book a free, personalized onboarding call with one of our cybersecurity experts.